Methyl 4-hydroxy-6-(trifluoromethyl)quinoline-2-carboxylate, 95.0%, 250mg

Phenazin-1-ol, 98%, 1g

Methyl 4-fluoro-3-sulfamoylbenzoate, 98%, 5g

Methyl 3-[(dimethylamino)methyl]-5-fluorobenzoate hydrochloride, 95.0%, 2g

4-Bromo-2,5-dichlorobenzoic acid, 95.0%, 10g

4-(4-Propylbenzoyl)isoquinoline, 97.0%, 1g

1-Chloro-4-[(dichloromethyl)sulfonyl]benzene, 100mg

(2E)-1-(4-bromophenyl)-3-(4-ethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

5-Cyclohexylpentanoic acid, 98%, 1g

1-(4-Boc-amino-1-butyl)-piperazine, 95.0%, 1g

(2E)-3-(2-chloro-6-fluorophenyl)-1-(4-ethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

3-hydroxy-7-oxaspiro[3.5]non-2-en-1-one, 98%, 50mg

Recipiente de evaporación ROTILABO® con fondo plano, 10 ml, 10 Unidad(es)